Robert William Freilich is a Lexington, Kentucky based male rheumatologist who is specialized in Rheumatology. Active license number of Robert William Freilich for Rheumatology is 58816 in Kentucky. Robert William Freilich treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Robert William Freilich speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D. - P.H.D
Gender:
Male
Practice Address:
740 S Limestone, Lexington, Kentucky, 40536-6402
Phone:
859-323-6700
Fax:
859-257-1331
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1871972067
NPI Enumeration Date:
21 May, 2015
NPI Last Update On:
18 Dec, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Robert William Freilich are as mentioned below.
License Number
Specialization
State
Status
58816
Rheumatologist
Kentucky
Primary
302123
Rheumatology
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
550 1st Ave, New York, New York
Zip:
10016-6402
Phone Number:
646-929-7870
Fax Number:
--
Patients can reach Robert William Freilich at 740 S Limestone, Lexington, Kentucky or can call to book an appointment on 859-323-6700. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.